Study led by Akron Children's finds pro2cool's hypothermic therapy reduces adolescent concussion symptoms
Retrieved on:
Tuesday, April 2, 2024
RN, Brain, Head, Medicine, Concussion, Ageing, Dayton Children's Hospital, Research, University, Doctor of Philosophy, University of Michigan, Frank R. McNinch, Adolescence, E pluribus unum, Hospital, Pain, Ice, Food, Swelling, FDA, Northeast Ohio Medical University, Parent, Neck, Sports medicine, Medical device
AKRON, Ohio, April 2, 2024 /PRNewswire/ -- Researchers at Akron Children's, Cincinnati Children's, University of Michigan and Dayton Children's Hospital, have found that hypothermic therapy reduces symptom severity after concussion.
Key Points:
- AKRON, Ohio, April 2, 2024 /PRNewswire/ -- Researchers at Akron Children's, Cincinnati Children's, University of Michigan and Dayton Children's Hospital, have found that hypothermic therapy reduces symptom severity after concussion.
- After a second treatment using the pro2cool® system, SCAT5 scores were 25% lower than those receiving standard concussion care.
- It is the first and only concussion treatment study of this population, and the largest single concussion therapy trial known to date.
- Now, in addition to brain rest, concussion symptoms can be treated with selective hypothermic therapy.